08:19 EDT Rapport Therapeutics (RAPP) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPP:
- Rapport Therapeutics reports Q4 EPS (72c), consensus (67c)
- Rapport Therapeutics sees cash runway into 2H29
- Rapport, Tenacia announce collaboration for RAP-219 in Greater China
- Rapport Therapeutics Completes Key Phase 2a Epilepsy Study for RAP-219: What Investors Should Watch Next
- Rapport Therapeutics initiated with an Overweight at Wells Fargo